Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostaglandin E synthase 3 pseudogene 3 (PTGES3P3) is a genomic locus annotated as a pseudogene related to prostaglandin E synthase 3. Pseudogenes are DNA sequences that resemble genes but are generally non-functional due to mutations, deletions, or truncations that prevent protein expression. PTGES3P3 does not encode an active enzyme or receptor, and there are no published data indicating a biological function, disease relevance, or drug interactions. It is not considered a therapeutic target or biomarker. The canonical gene/protein "Prostaglandin E synthase 3" (PTGES3) is an active enzyme involved in prostaglandin biosynthesis and may be a therapeutic target, but the "pseudogene 3" version (PTGES3P3) does not encode a functional protein and is not used in research or clinical practice as a target. Including "pseudogene" in the target selection process for drug discovery typically indicates a mistake or misinterpretation of genomic annotation. No aliases, molecular classification, disease associations, or drug interactions are reported for PTGES3P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin E synthase 3 pseudogene 3 (PTGES3P3).